Centaurus Financial, Inc. Eli Lilly & CO Transaction History

Centaurus Financial, Inc.

$1.44 Billion
Q3 2024

A detailed history of Centaurus Financial, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Centaurus Financial, Inc. holds 11,463 shares of LLY stock, worth $8.68 Million. This represents 0.71% of its overall portfolio holdings.

Number of Shares

11,463

Previous 6,099 87.95%

Holding current value

$8.68 Million

Previous $5.52 Million 83.93%

% of portfolio

0.71%

Previous 0.39%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$772.14 - $960.02 $4.14 Million - $5.15 Million	5,364 Added 87.95%	11,463 $10.2 Million
Q2 2024 Sep 20, 2024	BUY	$724.87 - $909.04 $2.24 Million - $2.8 Million	3,085 Added 102.36%	6,099 $5.52 Million
Q1 2024 May 14, 2024	BUY	$592.2 - $792.28 $598,714 - $800,995	1,011 Added 50.47%	3,014 $2.34 Million
Q4 2023 Feb 26, 2024	BUY	$525.19 - $619.13 $18,381 - $21,669	35 Added 1.78%	2,003 $1.17 Million
Q3 2023 Nov 13, 2023	SELL	$434.7 - $599.3 $297,769 - $410,520	-685 Reduced 25.82%	1,968 $1.06 Million
Q2 2023 Aug 15, 2023	SELL	$350.74 - $468.98 $549,960 - $735,360	-1,568 Reduced 37.15%	2,653 $1.24 Million
Q1 2023 May 17, 2023	SELL	$310.63 - $364.82 $186,067 - $218,527	-599 Reduced 12.43%	4,221 $1.45 Million
Q4 2022 Feb 10, 2023	BUY	$321.55 - $374.67 $304,829 - $355,187	948 Added 24.48%	4,820 $1.76 Million
Q3 2022 Dec 05, 2022	BUY	$296.48 - $337.87 $137,566 - $156,771	464 Added 13.62%	3,872 $1.25 Million
Q2 2022 Aug 02, 2022	BUY	$278.73 - $327.27 $304,373 - $357,378	1,092 Added 47.15%	3,408 $1.11 Million
Q1 2022 May 13, 2022	SELL	$234.69 - $291.66 $1,877 - $2,333	-8 Reduced 0.34%	2,316 $663,000
Q4 2021 Feb 01, 2022	BUY	$224.85 - $279.04 $77,123 - $95,710	343 Added 17.31%	2,324 $642,000
Q3 2021 Nov 12, 2021	BUY	$221.6 - $272.71 $438,989 - $540,238	1,981 New	1,981 $458,000
Q2 2021 Aug 10, 2021	SELL	$180.55 - $233.54 $111,218 - $143,860	-616 Closed	0 $0
Q1 2021 Apr 30, 2021	BUY	$164.32 - $212.72 $101,221 - $131,035	616 New	616 $115,000
Q3 2018 Nov 05, 2018	SELL	$85.86 - $107.31 $533,534 - $666,824	-6,214 Closed	0 $0
Q2 2018 Aug 15, 2018	BUY	$75.7 - $86.88 $239,136 - $274,453	3,159 Added 103.4%	6,214 $530,000
Q1 2018 May 07, 2018	BUY	$74.21 - $87.6 $226,711 - $267,618	3,055 New	3,055 $236,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $720B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Centaurus Financial, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Centaurus Financial, Inc. with notifications on news.

Account

Centaurus Financial, Inc. Eli Lilly & CO Transaction History